Phase III Study of Efaproxiral As an Adjunct to Whole-Brain Radiation Therapy for Brain Metastases

2005194 citationsJournal Articlebronze Open Access

Authors

John H. Suh

Baldassarre Stea · Université de Montréal

Abdenour Nabid · Université de Montréal

John J. Kresl · Université de Montréal

A. Fortin · Université de Montréal

Jean-Philippe Mercier · Université de Montréal

Neil Senzer · Université de Montréal

Abstract

The addition of efaproxiral, a noncytotoxic radiation sensitizer, to WBRT may improve response rates and survival in patients with brain metastases, particularly metastases from breast cancer. A confirmatory trial for breast cancer patients has been initiated.

Topics & Keywords

Brain Metastases and Treatment Lung Cancer Research Studies Lanthanide and Transition Metal Complexes

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 24, Issue 1, pp. 106-114

DOI: 10.1200/jco.2004.00.1768

Field-Weighted Citation Impact: 10.75